Use and costs of disease monitoring in women with metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms

abstract

  • Despite an unknown clinical benefit, approximately one third of elderly women with MBC were extreme users of disease-monitoring tests. Higher use of disease-monitoring tests was associated with higher total health care costs. Efforts to understand the optimal frequency of monitoring are needed to inform clinical practice.

publication date

  • August 20, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5012664

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.66.6313

PubMed ID

  • 27161970

Additional Document Info

start page

  • 2820

end page

  • 6

volume

  • 34

number

  • 24